RxDoctor Payments Data

Brian Smith, MD

Family Medicine · Lake St Louis, MONPI 1780645408

Payments from drug & device makers

$493in general payments, 2019–2025

Across 20 payments — averaging $24.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rigel Pharmaceuticals, Inc.$120
  • Regeneron Healthcare Solutions, Inc.$93
  • Gilead$62
  • AstraZeneca$55
  • Incyte Corporation$30
  • Avion Pharmaceuticals$28
  • plus $104 from 5 others

What the payments were for

  • Food & beverage$493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$493 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$69,575
Medicare patients
252
Services billed
724

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide84$144,292
JardianceEmpagliflozin99$116,189
EliquisApixaban116$113,864
MounjaroTirzepatide70$85,009
TrulicityDulaglutide49$68,561
JanuviaSitagliptin Phosphate20$25,310
FarxigaDapagliflozin Propanediol19$13,140
MyrbetriqMirabegron27$12,888
AbrysvoRsv Vacc, Pref A And Pref B/Pf48$11,522
Breo ElliptaFluticasone/Vilanterol11$10,543
Duloxetine Hcl341$8,710
Gabapentin252$8,694
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$6,723
ArexvyRsvpref3 Antigen/As01e/Pf27$6,284
Amlodipine Besylate808$4,987

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$55$13,14019 claims
Astellas Pharma US IncMyrbetriq$23$12,88827 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Lake St Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →